Types segmentation distinguishes the technological construction of Medical Assistive Devices, a key determinant of cost structure and regulatory pathway. Mechanical devices—such as manual wheelchairs, crutches, and orthopedic braces—represent roughly 31 % of market volume, reflecting lower unit costs and widespread use in low‑resource settings. Electrical devices, encompassing powered mobility aids, infusion pumps, and electric standing frames, account for about 34 % of revenue, driven by battery‑technology advances and increasing patient preference for motorized solutions. Electronic and sensor‑integrated devices—including smart inhalers, wearable activity monitors, and automated medication dispensers—contribute 22 % as data‑centric care models expand. Software‑enabled platforms, exemplified by tele‑rehabilitation applications and AI‑driven diagnostic assistants, hold 9 % of the market, indicating early‑stage adoption but high growth potential. Finally, hybrid systems that combine mechanical structures with electronic control modules, such as robotic exoskeletons, comprise the remaining 4 %. By quantifying each type’s share, the market taxonomy clarifies how engineering complexity translates into differentiated pricing, compliance requirements, and overall market size within the Medical Assistive Devices segmentation.